Is your company one of Fast Company's 10 most innovative medical device firms, now in their own category in the annual World’s Most Innovative Companies list?
![2A8XP71 (1).jpg]( "2A8XP71 (1).jpg")
The Warsaw, IN-based company is launching an artificial intelligence model to predict post-operative recovery progress.
Memic Innovative Surgery and Medtech Acquisitions have mutually terminated a planned merger.
The blood-based test is the first ever to simultaneously identify if a patient has cancer and if it has spread.
After recalling the HawkOne Directional Atherectomy System earlier this year, Medtronic is also recalling (correcting) its TurboHawk Plus Directional Atherectomy System due to design similarities with the HawkOne.
The new system has a smaller footprint, and is fully automated to improve testing volumes, and operational efficiency.
FDA approval of a recharge-free system could drive additional market share gains for Medtronic's sole competitor in the sacral nueromodulation space.
With this latest financing, the Boston, MA-based company has now raised a total of $111 million.
Saluda Medical has won FDA approval for its Evoke Spinal Cord Stimulation System.
Quickly catch up on the latest medtech news from Johnson & Johnson, Dexcom, Pear Therapeutics, and Others
